The most recent FDA approval belongs to BCG plus N-803, which has an initial complete response of 62%, falling to just 36% at 12 months. For technologies currently under clinical evaluation, ...

Teratomas are unique embryonal tumors from germ cells, containing diverse tissues like teeth, hair, and muscle, with ...